National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
Acta Pharmacol Sin. 2022 Feb;43(2):295-306. doi: 10.1038/s41401-021-00760-y. Epub 2021 Sep 14.
Behavioral sensitization is a progressive increase in locomotor or stereotypic behaviours in response to drugs. It is believed to contribute to the reinforcing properties of drugs and to play an important role in relapse after cessation of drug abuse. However, the mechanism underlying this behaviour remains poorly understood. In this study, we showed that mTOR signaling was activated during the expression of behavioral sensitization to cocaine and that intraperitoneal or intra-nucleus accumbens (NAc) treatment with rapamycin, a specific mTOR inhibitor, attenuated cocaine-induced behavioural sensitization. Cocaine significantly modified brain lipid profiles in the NAc of cocaine-sensitized mice and markedly elevated the levels of phosphatidylinositol-4-monophosphates (PIPs), including PIP, PIP and PIP. The behavioural effect of cocaine was attenuated by intra-NAc administration of LY294002, an AKT-specific inhibitor, suggesting that PIPs may contribute to mTOR activation in response to cocaine. An RNA-sequencing analysis of the downstream effectors of mTOR signalling revealed that cocaine significantly decreased the expression of SynDIG1, a known substrate of mTOR signalling, and decreased the surface expression of GluA2. In contrast, AAV-mediated SynDIG1 overexpression in NAc attenuated intracellular GluA2 internalization by promoting the SynDIG1-GluA2 interaction, thus maintaining GluA2 surface expression and repressing cocaine-induced behaviours. In conclusion, NAc SynDIG1 may play a negative regulatory role in cocaine-induced behavioural sensitization by regulating synaptic surface expression of GluA2.
行为敏化是指药物引起的运动或刻板行为的逐渐增加。它被认为是药物强化作用的原因之一,并在药物滥用停止后复发中发挥重要作用。然而,这种行为的机制仍知之甚少。在这项研究中,我们表明,mTOR 信号在可卡因诱导的行为敏化表达过程中被激活,腹腔内或核内伏隔核(NAc)给予雷帕霉素(一种特异性 mTOR 抑制剂)可减弱可卡因诱导的行为敏化。可卡因显著改变了可卡因敏化小鼠 NAc 中的脑脂质谱,并显著升高了磷脂酰肌醇-4-单磷酸盐(PIPs)的水平,包括 PIP、PIP 和 PIP。NAc 内给予 AKT 特异性抑制剂 LY294002 可减弱可卡因的行为效应,表明 PIPs 可能有助于可卡因诱导的 mTOR 激活。mTOR 信号下游效应物的 RNA 测序分析表明,可卡因显著降低了 SynDIG1 的表达,SynDIG1 是 mTOR 信号的已知底物,同时降低了 GluA2 的表面表达。相比之下,AAV 介导的 SynDIG1 在 NAc 中的过表达通过促进 SynDIG1-GluA2 相互作用,减少细胞内 GluA2 内化,从而维持 GluA2 的表面表达并抑制可卡因诱导的行为,从而减弱了 NAc 内的 GluA2 内化。总之,NAc SynDIG1 可能通过调节 GluA2 的突触表面表达来负调控可卡因诱导的行为敏化。